Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biohaven (BHVN) Cash & Current Investments (2021 - 2026)

Biohaven has reported Cash & Current Investments over the past 6 years, most recently at $347.8 million for Q1 2026.

  • Quarterly results put Cash & Current Investments at $347.8 million for Q1 2026, up 7.77% from a year ago — trailing twelve months through Mar 2026 was $347.8 million (up 7.77% YoY), and the annual figure for FY2025 was $319.1 million, down 34.33%.
  • Cash & Current Investments reached $347.8 million in Q1 2026 per BHVN's latest filing, up from $319.1 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $486.0 million in Q4 2024 and bottomed at $23.2 million in Q2 2022.
  • Median Cash & Current Investments over the past 5 years was $322.7 million (2025), compared with a mean of $295.2 million.
  • The largest annual shift saw Cash & Current Investments tumbled 85.99% in 2022 before it skyrocketed 863.86% in 2023.
  • Over 5 years, Cash & Current Investments stood at $465.3 million in 2022, then fell by 17.95% to $381.8 million in 2023, then increased by 27.28% to $486.0 million in 2024, then tumbled by 34.33% to $319.1 million in 2025, then rose by 8.99% to $347.8 million in 2026.
  • Business Quant data shows Cash & Current Investments for BHVN at $347.8 million in Q1 2026, $319.1 million in Q4 2025, and $260.2 million in Q3 2025.